Filing Flows › NeuroPace (NPCE) › Q4 2024
NeuroPace (NPCE) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 4, 2025
NeuroPace (NPCE) reported revenue of $21.5M for the fourth quarter 2024 (Q4 2024), +19% from a year earlier and +2% from the quarter before. Operating margin was -17.0%, net loss $5.2M (24.5% of revenue).
NeuroPace, Q4 2024: revenue $21.5M (+19% year over year), operating margin -17.0%, net loss $5.2M, operating cash flow −$4.8M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.5M | +2% | +19% |
| Operating profit | −$3.7M | — | — |
| Net earnings | −$5.2M | — | — |
| Operating cash flow | −$4.8M | — | — |
What changed
Revenue was $21.5M in Q4 2024, up 19% year over year and up 2% from the previous quarter.
Gross margin was 75.4%, up 0.2 points from a year earlier. Operating costs exceeded revenue by $3.7M, an operating margin of -17.0%. Operating expenses grew 7% against revenue growth of 19%. The fastest-growing cost line was Research & development (+13%). The quarter ended with a net loss of $5.2M, narrower than the previous quarter's $5.5M loss.
Operating cash flow was −$4.8M. Non-cash charges added back $48K of depreciation and $2.6M of share-based compensation. Working capital and other items used $2.2M. Capital expenditures of $39K exceeded it, leaving free cash flow of −$4.8M.
Questions
What was NeuroPace's revenue in the fourth quarter 2024?
NeuroPace (NPCE) reported revenue of $21.5M for the fourth quarter 2024 (Q4 2024), +19% from a year earlier and +2% from the quarter before.
Was NeuroPace profitable in the fourth quarter 2024?
Operating loss was $3.7M (-17.0% of revenue) and net loss $5.2M.
Source: NeuroPace 10-K on SEC EDGAR.